Target intelligence / Profile preview

Escherichia coli K99 fimbrial antigen (K99)

Target
K99
Molecular classification
Bacterial adhesin, Fimbrial protein, Surface antigen
01

Overview

The Escherichia coli K99 fimbrial antigen, also known as F5, is a major virulence factor of enterotoxigenic Escherichia coli (ETEC) that causes severe, often fatal, diarrhea in neonatal ruminants and swine (Moon et al., 1977). It is a proteinaceous, filamentous surface appendage composed primarily of the FanC subunit, which facilitates the adherence of the bacteria to the intestinal epithelium by binding to N-glycolylneuraminic acid-containing receptors (Kyogashima et al., 1989; UniProt P02971). This attachment is a mandatory prerequisite for the bacteria to colonize the small intestine and deliver heat-stable enterotoxins (STa), which disrupt electrolyte balance and lead to significant economic losses in the livestock industry (Acosta-Dibarrat et al., 2007). Therapeutic and preventive strategies focus on blocking this adhesion through the use of maternal vaccines or the oral administration of monoclonal antibodies to neonates (Castrucci et al., 1988). Because the K99 antigen is highly conserved among pathogenic ETEC strains, it serves as an effective target for broad-spectrum veterinary immunotherapies and diagnostic assays (Mainil, 2013). Current commercial products like ScourGuard and Guardian utilize this antigen to induce protective colostral immunity in pregnant dams (Zoetis; Merck Animal Health).

Other names
F5 fimbriaeK99 pilusFanC proteinEnterotoxigenic E. coli K99 antigenF5 adhesin
02

Mechanism of action

Prevention of bacterial attachment to the intestinal mucosa by inducing or providing specific antibodies that bind to the fimbrial subunits, thereby blocking colonization and subsequent toxin delivery.

03

Biological functions

Bacterial adhesionIntestinal colonizationPathogenesis
04

Disease associations

InfectionNeonatal diarrheaColibacillosis
05

Safety considerations

Injection site reactions in livestockMaternal antibody interference in neonatesPotential for hypersensitivity to vaccine components
06

Interacting drugs

ScourGuard 4KC

4 more in the full profile.

07

Biomarkers

K99 antigen detection in feces (ELISA/PCR)Anti-K99 antibody titers in colostrum

Beyond the preview

Go deeper on Escherichia coli K99 fimbrial antigen (K99).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Escherichia coli K99 fimbrial antigen (K99).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call